Phase II Study of Maintenance Rucaparib in Patients With Platinum-Sensitive Advanced Pancreatic Cancer and a Pathogenic Germline or Somatic Variant in BRCA1, BRCA2, or PALB2 A retrospective decedent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results